MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

Alta Advisers boosted its Amgen stake by nearly 50% this quarter, owning shares worth $844,000 at last count. Vanguard, ...

Wall Street optimistic for July 4 weekend, sees opportunities in Freeport-McMoRan, Honeywell, Caterpillar, and Amgen.

Biocon failed to provide critical information about proposed denosumab product, Amgen claims | Company expects ‘sales erosion ...

Amgen Inc. (NASDAQ: AMGN) is one of the. On June 23, the company announced full results from Part 1 of the Phase 2 study of ...

Amalgamated Bank increased its stake in Amgen by 2.2% in Q1, buying 2,392 more shares and bringing its total to 112,254.

Shares of Health Care sector company Amgen moved 1.4% today, and are now trading at a price of $294.45. The Large-Cap stock's ...

Newsom backtracks on return to office order for California workers amid union demands ...

Topline data were announced from a phase 3 trial evaluating bemarituzumab plus chemotherapy in individuals with gastric or gastroesophageal junction cancer with FGFR2b overexpression.

Eli Lilly and Novo Nordisk, which already have approved GLP-1 weight loss drugs that are raking in billions of revenues, have ...

The Dow Dow Jones Industrial Average was most recently trading 492 points higher (1.1%), as shares of Amgen Amgen Inc. and Merck Merck & Co. Inc. have contributed around 25% of the blue-chip gauge's ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with significant health benefits.